Kalkine has a fully transformed New Avatar.

KALIN®

Kalkine Daily 02/06/2015 + MAGELLAN FINANCIAL

Jun 03, 2015

In today’s daily we have covered stock research on MAGELLAN FINANCIAL (EXPENSIVE).









 

The S&P 500 was up by 4.34 points or 0.21% to 2111.73 on Monday.  U.S. stocks ended with modest gains on Monday, recovering part of last week's losses in a session marked by cautious trading as investors reacted to mixed economic data. A report from ISM showed the pace of manufacturing growth rose in May. Other data showed construction spending surged in April but consumer spending was unexpectedly flat.

Immunogen surged more than 70 percent, leading a rally in cancer drug makers' stocks after they presented positive data at a conference. Bristol-Myers shares jumped 2.9 percent to $66.48, giving the S&P 500 its biggest boost, after the FDA accepted its application for a combination melanoma treatment. Intel fell 1.6 percent to $33.90 and was the biggest drag on the three major indexes after the company agreed to buy programmable-chip maker Altera for $16.7 billion. Alterarose 5.8 percent to $51.68.




S&P 500 Daily Chart (Source - Thomson Reuters)
 

S&P ASX 200 was down by 41.80 points or 0.72% on Monday and closed at 5735.40 points. Among the banks, ANZ lost 1.4 per cent to $32.72, Commonwealth Bank weakened 0.7 per cent to $84.48, National Australia Bank shed 0.8 per cent to $34.03 and Westpac slipped 1.3 per cent to $33.12.  Miners bore the brunt of the decline, despite a firmer iron ore price. BHP shed 1.4 per cent to $29.19 while Rio Tinto fell back 1.3 per cent to $57.42. Fellow blue-chip Telstraperformed better, only dropping 0.3 per cent to $6.20.  

Sirtex shares resumed trading on Monday after presenting in the US over the weekend the final report on its Sirflox product. The report showed an additional 7.9 months of "progression-free" survival for liver cancer patients who used the company's flagship product, pushing shares 14.3 per cent higher to $30.52. An improving oil price helped local producers. Santos lifted 0.8 per cent to $8.32 and Oil Search added 1.5 per cent to $7.71. Woodside, however, shaved 0.2 per cent to $36.56.


SIRTEX Daily Chart (Source - Thomson Reuters)


Top Performers ASX 200 :-



 


 

Get up to 2 Years of free subscription by inviting your friends to KALKINE!

For every friend of yours who joins KALKINE, we'll give you 3 months of free subscription (up to a limit of 24 months free subscription). If you recommend 3 friends and they join within a month of you referring them, you get 1 year free subscription to KALKINE reports added to your account (up to a limit of 24 months free subscription). Simply reply to this email with their name, e-mail and phone number.
 






 

Stock Of The Day - Magellan Financial (EXPENSIVE)

Magellan Financial Group Limited is an active international equity and infrastructure investment manager. Near-term earnings growth is underpinned by strong growth in funds under management, or FUM, complemented by increasing performance fees. A long record of investment outperformance supports further growth in FUM. Major earnings risks flow from the need to deliver good investment returns and the volatile nature of large institutional mandates. Attractive long-term industry dynamics are supported by increasing numbers of Australian investors seeking international equity exposure to diversify typically Australian-centric portfolios. Magellan does not focus on short-term performance, instead seeks high-quality stocks likely to produce strong long-term returns through the business cycle.
 

Magellan Global Fund FUM & Net Inflows (Source - Company Reports)

Magellan is really in a sweet spot, benefiting from strong investment performance, a lower Australian dollar, and growing demand for international equity exposure from Australian retail investors. Magellan announced FUM of AUD 35.8 billion at 31 March 2015. Despite the high concentration of FUM in global equity funds, about 26% of total FUM is sourced from sticky, higher margin domestic retail investors. Total inflows of AUD 336 million and AUD 122 million in positive revaluations for March boosted total FUM by a net AUD 458 million. Institutional net inflows were AUD 77 million lower, at AUD 160 million, while retail net inflows, which we typically view as stickier and usually higher-margin, almost doubled, to AUD 176 million.


Total Funds Under Management as of APRIL 2015 (Source - Company Reports)

April saw institutional net outflows of A$73m with “minor rebalancing by a number of clients”. In our view, a narrow product range with no European equities or Asian equities funds is also a headwind in the current environment. Longer term, a normalising 3 Year track record likely makes it tough for MFG to sustain elevated institutional flows. This was just the third monthly outflow in the past three years. After averaging ~A$150m per month in FY13/14 and A$100m in 1H15, March retail flows into the Global Fund were A$117m. The new Exchange Traded Managed Fund (MGE) contributed A$38m, down from A$74m in March, with the initial demand rush abating and the daily run rate settling.


Magellan Global Fund Exposure (Source - Company Reports)

The recent launch of the ASX-listed Magellan Global Equities Fund (MGE) potentially opens up access to Magellan's successful unlisted Global Fund to individual investors comfortable with trading ASX-listed securities. This unique product initiative has the potential to attract substantial domestic fund flows from retail investors, especially those seeking to diversify their portfolio exposure away from the highly concentrated Australian market.


Magellan Financial Daily Chart (Source - Thomson Reuters)

Despite its very strong operational performance, Magellan carries higher risk than the larger more diversified medium risk asset managers. This is due to the firm’s relatively short life, explosive growth, key personnel risk, and reliance on a small number of investment strategies. Magellan is very different from most Australian-based asset managers, as it is focusing almost entirely on international equities, and raises most of its wholesale FUM from international institutional investors.

Despite solid growth in higher-margin retail funds under management, or FUM, weighted average margins are declining due to strong growth in lower margin institutional FUM. Margin pressure from within the retail and institutional client base would reduce profitability. A shift in institutional investor demand for quality global equity strategies would depress institutional flow. Contrary to larger peers, Magellan's FUM is concentrated in seven international equity and infrastructure funds. This concentration risk increases the volatility of FUM going forward. We believe the stock is expensive at current price and would review the stock at a later date.
 



 


 

 

 


Level 13  167 Macquarie Street
Sydney NSW 2000 Australia
E-Mail - [email protected]
Phone - 02 8667 3147


        
Note - You can also view this daily in the special reports section.

 


Disclaimer
The advice given by Kalkine Pty Ltd and provided on this website is general information only and it does not take into account your investment objectives, financial situation or needs. You should therefore consider whether the advice is appropriate to your investment objectives, financial situation and needs before acting upon it. You should seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) as necessary before acting on any advice. Not all investments are appropriate for all people.
Kalkine.com.au and associated pages are published by Kalkine Pty Ltd ABN 34 154 808 312 (Australian Financial Services License Number 425376).
The information on this website has been prepared from a wide variety of sources, which Kalkine Pty Ltd, to the best of its knowledge and belief, considers accurate. You should make your own enquiries about any investments and we strongly suggest you seek advice before acting upon any recommendation.
Kalkine Pty Ltd has made every effort to ensure the reliability of information contained in its newsletters and websites. All information represents our views at the date of publication and may change without notice. To the extent permitted by law, Kalkine Pty Ltd excludes all liability for any loss or damage arising from the use of this website and any information published (including any indirect or consequential loss, any data loss or data corruption). If the law prohibits this exclusion, Kalkine Pty Ltd hereby limits its liability, to the extent permitted by law to the resupply of services. There may be a product disclosure statement or other offer document for the securities and financial products we write about in Kalkine Reports. You should obtain a copy of the product disclosure statement or offer document before making any decision about whether to acquire the security or product.
The link to our Terms & Conditions has been provided please go through them and also have a read of the Financial Services Guide.